(Q44563635)

4 December 2017

title

Indole-based heterocyclic inhibitors of p38alpha MAP kinase: designing a conformationally restricted analogue (English)

1 reference

4 December 2017

Babu J Mavunkel

1

1 reference

4 December 2017

Sarvajit Chakravarty

2

1 reference

4 December 2017

John J Perumattam

3

1 reference

4 December 2017

Gregory R Luedtke

4

1 reference

4 December 2017

Xi Liang

5

1 reference

4 December 2017

Don Lim

6

1 reference

4 December 2017

Yong-jin Xu

7

1 reference

4 December 2017

Maureen Laney

8

1 reference

4 December 2017

David Y Liu

9

1 reference

4 December 2017

George F Schreiner

10

1 reference

4 December 2017

John A Lewicki

11

1 reference

4 December 2017

Sundeep Dugar

12

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bioorganic & Medicinal Chemistry Letters

4 December 2017

published in

1 reference

4 December 2017

volume

13

1 reference

4 December 2017

issue

18

1 reference

4 December 2017

page(s)

3087-3090

1 reference

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

The primary structure of p38 gamma: a new member of p38 group of MAP kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Pyrroles and other heterocycles as inhibitors of p38 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Suppression of the clinical and cytokine response to endotoxin by RWJ-67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

RPR203494 a pyrimidine analogue of the p38 inhibitor RPR200765A with an improved in vitro potency

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Modulation of signal-transduction pathways by chemopreventive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

Alterations of MAPK activities associated with intestinal cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

(R)-3,3,3-Trifluoro-2-hydroxy-2-methylpropionamides are orally active inhibitors of pyruvate dehydrogenase kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900653-X

7 January 2021

10.1016/S0960-894X(03)00653-X

Identifiers

DOI

1 reference

4 December 2017

1 reference